Results 191 to 200 of about 120,861 (346)

129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative

David Parra, Jeffery L. Kibert, Natalie R. Ciccone, Litzalee Camacho-Vega, Joseph Capriola, Jennifer Crowley, Joseph J. Fierro, Alida Marrero-Hernandez, Maria J. Irias, Robert D. Stewart, Jaclyn Stoppi, Emily Wilson, Laura K. Vinieratos   +12 more
openalex   +2 more sources

Supplementary Table 1 from Intake of Proton-Pump Inhibitors and Gastric Cancer within the Stomach Cancer Pooling (StoP) Project [PDF]

Michele Sassano, Marco Mariani, Claudio Pelucchi, Nuno Lunet, Samantha Morais, Vicente Martín, Vı́ctor Moreno, María Paula Curado, Emmanuel Dias‐Neto, Mārcis Leja, Evita Gašenko, Carlo La Vecchia, Stefania Boccia, Roberta Pastorino   +13 more
openalex   +1 more source

APPROPRIATENESS OF PROTON PUMP INHIBITOR USE IN A PSYCHOGERIATRIC POPULATION [PDF]

, 2017
Ivanka Hendrix, Renuka Visvanathan
openalex   +1 more source

Gut Bacterium Lysinibacillus Sphaericus Exacerbates Aspirin‐induced Intestinal Injury by Production of Carboxylesterase EstB

Advanced Science, EarlyView.
Schematic overview illustrating the detrimental role of gut microbiota in aspirin‐induced intestinal injury. L. sphaericus and its secreted carboxylesterase EstB are identified as key drivers that catalyze aspirin hydrolysis into salicylic acid, thereby exacerbating intestinal injury. Inhibition of EstB by the dietary compound flavanomarein effectively
Zeyu Zhao, Qing Li, Xiaowu Bai, Ertao Zhai, Weigang Dai, Yan Qian, Tianhao Zhang, Zhixin Huang, Ziyu Huang, Fangang Meng, Jianhui Chen, Tao Zuo, Shirong Cai, Risheng Zhao   +13 more
wiley   +1 more source

Proton Pump Inhibitor-Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy. [PDF]

DEN Open
Ikeda R, Kaneko H, Sato H, Matsuoka Y, Hamaguchi T, Ikeda A, Goda Y, Sue S, Irie K, Maeda S.   +9 more
europepmc   +1 more source

A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD

Dasi Sharath Chandra, Nikhitha Pulipeta, Nishat Bilal, Mohamed Bilal Azam   +3 more
openalex   +2 more sources

HTRS2023.O8A.4 Proton pump inhibitors are an additive risk factor for hormonal contraception related thrombosis

, 2023
Clayton Habiger, David A. Hanauer, Murat Yaman, Jordan A. Shavit   +3 more
openalex   +1 more source

NIR Light‐Driven Photocatalytic Antibacterial Hydrogels for Synergistic MRSA Biofilm Eradication and Wound Regeneration

Advanced Science, EarlyView.
The nanohybrid hydrogel (Fe‐BOS@C/H Gel) is composed of Fe‐Bi2O2‐XS (Fe‐BOS) photocatalysts and CS‐ADH/OHA (C/H) hydrogel. Fe‐BOS photocatalysts achieve near‐infrared (NIR) light‐driven antibacterial photocatalytic/mild photothermal therapy (APCT/MPTT), effectively eliminating methicillin‐resistant Staphylococcus aureus (MRSA) biofilms. The degradation
Dong Mo, Yujia Wei, Meng Pan, Wen Chen, Yun Yang, Kang Li, Xicheng Li, Jianan Li, Qingya Liu, Hanzi Deng, Mei Zhu, Zhenpeng Zhang, Zhaolin Xiao, Zhiyong Qian   +13 more
wiley   +1 more source

Proton pump inhibitors: perspectives of patients and their GPs.

, 2001
Andrew Williams
openalex   +1 more source

Table 1_Comparison of tegoprazan-based and proton pump inhibitor-based regimens for Helicobacter pylori eradication: a meta-analysis and systematic review.docx

Xin Zhang (35492), Xing Li (134367), Jiangguo Li (21565820), Yuexia Deng (17780919), Wei Xu (28953), Dongkui Chen (15424475), Licheng Wei (7066121)   +6 more
openalex   +1 more source